S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

RPRX Royalty Pharma PLC

28.28

-0.21 (-0.74%)

May 07 2024 - Closed

Delayed by 15 minutes

Sec Staff Action/letter (sec Staff)

This regulatory filing also includes additional resources:
filename1.pdf

Royalty Pharma (NASDAQ:RPRX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Royalty Pharma Charts.

Royalty Pharma (NASDAQ:RPRX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Royalty Pharma Charts.

Royalty Pharma Plc News

Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Friday 19 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Royalty Pharma Declares Second Quarter 2024 Dividend
Wednesday 17 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
Wednesday 28 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Royalty Pharma Reports Q4 and Full Year 2023 Results
Thursday 15 February 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 6 February 2024 (3 months ago) • Edgar (US Regulatory)

Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
Tuesday 30 January 2024 (3 months ago) • GlobeNewswire Inc.

Royalty Pharma Announces Dividend Increase
Friday 19 January 2024 (4 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 8 January 2024 (4 months ago) • Edgar (US Regulatory)

Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
Monday 8 January 2024 (4 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 3 January 2024 (4 months ago) • Edgar (US Regulatory)

More Royalty Pharma Plc News Articles

Moon Equity (PK)

Globestar Therapeutics (PK)

Greene Concepts (PK)

Blue Line Protection (PK)

MicroCloud Hologram

Therapeutic Solutions (PK)

Clean Vision (QB)

FuelCell Energy

Houston Natural Resources (PK)

Progressive Care (QB)

Innovation Pharmaceuticals (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions